Related Experiment Video
Updated: Jun 27, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Cardiac resynchronization therapy
1Division of Cardiology, Mayo Clinic College of Medicine, 200 First Street SW, Gonda 5-South, Rochester, MN 55902, USA.
Insights
Identifying mechanical dysfunction for device therapy remains challenging. Advanced imaging techniques like 3D echocardiography and cardiac MRI require tailored application to patient needs for improved treatment selection.
Area of Science:
- Cardiology
- Medical Imaging
- Biomedical Engineering
Background:
- Electrical and mechanical dyssynchrony are distinct clinical entities.
- Current noninvasive methods struggle to reliably identify mechanical dysfunction treatable with device therapy.
Purpose of the Study:
- To address the limitations in identifying mechanical dysfunction for device therapy.
- To emphasize a broader approach to assessing cardiac dyssynchrony.
Main Methods:
- Highlighting the PROSPECT (Predictors of Response to CRT) trial findings.
- Discussing the potential of real-time three-dimensional echocardiography and cardiac magnetic resonance imaging.
- Advocating for selective matching of imaging modality strengths to patient heterogeneity.
Main Results:
- The PROSPECT trial underscores the complexity of diagnosing mechanical dyssynchrony.
- No single noninvasive method currently offers consistent identification of correctable mechanical dysfunction.
Conclusions:
- A comprehensive and tailored approach is needed for assessing mechanical dyssynchrony.
- Maximizing and selectively applying advanced imaging modalities like 3D echo and cardiac MRI is crucial.
- Future research should focus on robust clinical studies matching imaging to patient populations.
Abstract:
It is now well established that electrical and mechanical dyssynchrony are not clinically synonymous; however, at present no individual noninvasive method can reliably and consistently identify the criteria for mechanical dysfunction correctable through device therapy. The results of the PROSPECT (Predictors of Response to CRT) trial not only highlight the complicated nature of this dilemma, but also emphasize the importance of broadening our approach to this topic. Not only do the capabilities of real-time three-dimensional echocardiography and cardiac magnetic resonance imaging need to be maximized, but the strengths and weaknesses of each modality need to be more selectively matched to the heterogeneity of this particular patient population and subsequently studied in a robust clinical fashion.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation III: AED Use
Heart Failure VI: Adjunct Therapies

